Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Horizon Therapeutics Plc market cap is $26.63B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Horizon Therapeutics Plc 52 week high is $116.38 as of May 02, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Horizon Therapeutics Plc 52 week low is $61.93 as of May 02, 2024.
Horizon Therapeutics Plc stock price today is $116.30.
Horizon Therapeutics Plc stock price yesterday was $116.25.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Horizon Therapeutics Plc’s P/E ratio is 62.16.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Horizon Therapeutics Plc P/B ratio is 5.0133.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Horizon Therapeutics Plc's EBITDA is 26.19.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Horizon Therapeutics Plc 50-day moving average is $111.80.